THE CLINICAL DEVELOPMENT OF CARFILZOMIB
Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients .
THE CLINICAL DEVELOPMENT OF CARFILZOMIB
Industry:
Biotechnology Health Care
Founded:
1992-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.onyx.com
Total Employee:
10001+
Status:
Active
Contact:
6502660784
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving IPv6 Microsoft CPanel SSL MailChimp CPanel OVH Apple Whitelist
Official Site Inspections
http://www.onyx.com
- Host name: ec2-52-40-42-113.us-west-2.compute.amazonaws.com
- IP address: 52.40.42.113
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
Loading ... 